438 A phase 1/2 trial of PTR-01, a collagen 7 (C7) protein replacement therapy, in patients with recessive dystrophic epidermolysis bullosa (RDEB) J. Tang,A. Bruckner, M. Chen,D.T. Woodley,D. Keene,M. Barriga, K. Peoples, R. Johnson,D. Ramsdell,H. LandyJournal of Investigative Dermatology（2021）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
